Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Novel model developed to predict amount of nicotine emitted from e-cigarettes

  • Depressed females have over-active glutamate receptor gene

  • Trying to quit smoking? First strengthen self-control

  • Take a Trip Through the Brain: New Imaging Tool

  • Positive reinforcement plays key role in cognitive task performance in ADHD kids

  • The body and the brain: Impact of mental, physical exertion on fatigue development

  • Depression, personality disorders drive psych patients to euthanasia

  • Seniors get mental health drugs at twice the rate of other adults, see psychiatrists less

  • Every country in the world can afford to support its smokers to stop

  • Depressive ruminations and the idling brain

  •